These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15993491)

  • 1. No changes in serum epidermal growth factor levels in patients with schizophrenia.
    Hashimoto K; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Takei N; Iyo M
    Psychiatry Res; 2005 Jun; 135(3):257-60. PubMed ID: 15993491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients.
    Futamura T; Toyooka K; Iritani S; Niizato K; Nakamura R; Tsuchiya K; Someya T; Kakita A; Takahashi H; Nawa H
    Mol Psychiatry; 2002; 7(7):673-82. PubMed ID: 12192610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
    Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
    Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism.
    Suzuki K; Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suda S; Sugihara G; Matsuzaki H; Sugiyama T; Kawai M; Minabe Y; Takei N; Mori N
    Biol Psychiatry; 2007 Aug; 62(3):267-9. PubMed ID: 17123472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients.
    Hänninen K; Katila H; Anttila S; Rontu R; Maaskola J; Hurme M; Lehtimäki T
    J Psychiatr Res; 2007; 41(1-2):8-14. PubMed ID: 16115648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
    Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
    Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
    Sarandol A; Kirli S; Akkaya C; Altin A; Demirci M; Sarandol E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1164-9. PubMed ID: 17459548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile.
    Pazvantoglu O; Selek S; Okay IT; Sengul C; Karabekiroglu K; Dilbaz N; Erel O
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):693-700. PubMed ID: 19788631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia.
    Ikeda Y; Yahata N; Ito I; Nagano M; Toyota T; Yoshikawa T; Okubo Y; Suzuki H
    Schizophr Res; 2008 Apr; 101(1-3):58-66. PubMed ID: 18289832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial evidence of an association between epidermal growth factor A61G polymorphism and age at onset in male schizophrenia.
    Lee KY; Ahn YM; Joo EJ; Joo YH; Chang JS; Yoo HY; Kim YS
    Neurosci Res; 2006 Dec; 56(4):356-62. PubMed ID: 16979250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
    Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
    Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of serum BDNF levels in drug-naive patients with schizophrenia.
    Rizos EN; Rontos I; Laskos E; Arsenis G; Michalopoulou PG; Vasilopoulos D; Gournellis R; Lykouras L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1308-11. PubMed ID: 18502013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency of Brief Psychiatric Rating Scale factor structure across a broad spectrum of schizophrenia patients.
    Kopelowicz A; Ventura J; Liberman RP; Mintz J
    Psychopathology; 2008; 41(2):77-84. PubMed ID: 18033976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.
    Gama CS; Salvador M; Andreazza AC; Kapczinski F; Silva Belmonte-de-Abreu P
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):512-5. PubMed ID: 16426720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
    Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia.
    Jow GM; Yang TT; Chen CL
    J Affect Disord; 2006 Jan; 90(1):21-7. PubMed ID: 16324751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor and gastrin in scleroderma/CREST syndrome.
    Jiménez-Balderas F; Zonana-Nacach A; Fonseca-Yerena ME; Ruíz-Chaparro A; Pascoe-Lira D
    Arch Med Res; 1998; 29(1):51-5. PubMed ID: 9556923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
    Emanuele E; Colombo R; Martinelli V; Brondino N; Marini M; Boso M; Barale F; Politi P
    Neuro Endocrinol Lett; 2010; 31(1):117-21. PubMed ID: 20150873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased serum neurotrophin 3 in chronically medicated schizophrenic males.
    Vargas HE; Gama CS; Andreazza AC; Medeiros D; Stertz L; Fries G; Palha J; Cereser KM; Berk M; Kapczinski F; Belmonte-de-Abreu PS
    Neurosci Lett; 2008 Aug; 440(3):197-201. PubMed ID: 18572319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.